Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatiana Mihalova

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|June 5, 2016
Severe tumefactive rebound of multiple sclerosis following fingolimod cessationSharfaraz Salam, Tatiana Mihalova, Rekha Siripurapu
BMJ Case Reports|February 27, 2021
Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatmentAram Aslanyan, Zoheb Anwar-Hashim, Rekha Siripurapu, et al.
BMJ Case Reports|June 24, 2016
Relapsing CD8+ encephalitis-looking for a solutionSharfaraz Salam, Tatiana Mihalova, Andrew Ustianowski, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosisKeh Yann, Fran Jackson, Nazar Sharaf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre studyJoyutpal Das, Gagana Mallawaarachchi, Jack Grimshaw, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|June 5, 2016
Severe tumefactive rebound of multiple sclerosis following fingolimod cessationSharfaraz Salam, Tatiana Mihalova, Rekha Siripurapu
BMJ Case Reports|February 27, 2021
Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatmentAram Aslanyan, Zoheb Anwar-Hashim, Rekha Siripurapu, et al.
BMJ Case Reports|June 24, 2016
Relapsing CD8+ encephalitis-looking for a solutionSharfaraz Salam, Tatiana Mihalova, Andrew Ustianowski, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosisKeh Yann, Fran Jackson, Nazar Sharaf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre studyJoyutpal Das, Gagana Mallawaarachchi, Jack Grimshaw, et al.
Pageof 1